Cargando…
Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease
Most allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients receive peripheral blood stem cell grafts resulting in a 30%–70% incidence of chronic graft-versus-host disease (cGVHD), a major cause of mortality and morbidity in long-term survivors. While systemic steroids remain the stand...
Autores principales: | Thangavelu, Govindarajan, Zaiken, Michael C., Mohamed, Fathima A., Flynn, Ryan, Du, Jing, Rhee, Stephanie Y., Riddle, Megan J., Aguilar, Ethan G., Panoskaltsis-Mortari, Angela, Sanders, Martin E., Blazar, Bruce R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963714/ https://www.ncbi.nlm.nih.gov/pubmed/35359939 http://dx.doi.org/10.3389/fimmu.2022.765319 |
Ejemplares similares
-
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019) -
Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
por: Mohamed, Fathima A., et al.
Publicado: (2021) -
Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease
por: Levy, Robert B., et al.
Publicado: (2021) -
Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022) -
High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease
por: Schultz, Brittney, et al.
Publicado: (2022)